Erin M Guest

13PUBLICATIONS
83CO-AUTHORS
Gene and molecular therapyHaematological tumoursMedical mycologyMedical infection agents (incl. prions)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Jun 24, 2025
Real-world data for tisagenlecleucel in patients with R/R B-ALL: subgroup analyses from the CIBMTR registry.

Samuel John, Kevin J Curran, Erin M Hall

|Aug 23, 2024
Menin inhibitors in pediatric acute leukemia: a comprehensive review and recommendations to accelerate progress in collaboration with adult leukemia and the international community.

Branko Cuglievan, Hagop Kantarjian, Jeffrey E Rubnitz

|Apr 15, 2024
Optimized cytogenetic risk-group stratification of KMT2A-rearranged pediatric acute myeloid leukemia.

Romy E van Weelderen, Christine J Harrison, Kim Klein

|Jun 01, 2023
Minimal residual disease predicts outcomes in KMT2A-rearranged but not KMT2A-germline infant acute lymphoblastic leukemia: Report from Children's Oncology Group study AALL0631.

Kelly E Faulk, John A Kairalla, ZoAnn E Dreyer

|Mar 30, 2023
Measurable Residual Disease and Fusion Partner Independently Predict Survival and Relapse Risk in Childhood KMT2A-Rearranged Acute Myeloid Leukemia: A Study by the International Berlin-Frankfurt-Münster Study Group.

Romy E van Weelderen, Kim Klein, Christine J Harrison

|Nov 15, 2022
Preclinical efficacy of azacitidine and venetoclax for infant KMT2A-rearranged acute lymphoblastic leukemia reveals a new therapeutic strategy.

Laurence C Cheung, Carlos Aya-Bonilla, Mark N Cruickshank

Pageof 3

Frequent Collaborators

2 joint publications

Mareike Rasche

2 joint publications

Midhat S Farooqi

2 joint publications

Henrik Hasle

2 joint publications

Sunmin Lee